Malignant Melanoma
Showing NaN - NaN of 29
Advanced Solid Tumor, Castration-Resistant Prostatic Cancer, Malignant Melanoma Trial in United States (MGC018, lorigerlimab)
Recruiting
- Advanced Solid Tumor
- +6 more
- vobramitamab duocarmazine
- lorigerlimab
-
Los Angeles, California
- +7 more
Jan 10, 2023
Advanced Solid Tumor, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in United States (STK-012,
Recruiting
- Advanced Solid Tumor
- +10 more
-
Boston, Massachusetts
- +8 more
Jan 2, 2023
Malignant Melanoma Trial in Worldwide (UV1, Sargramostim, Ipilimumab)
Recruiting
- Malignant Melanoma
- UV1
- +3 more
-
Phoenix, Arizona
- +39 more
Aug 16, 2022
Malignant Melanoma Trial in United States (BMS-936558 (MDX1106-04), Ipilimumab)
Completed
- Malignant Melanoma
- BMS-936558 (MDX1106-04)
- Ipilimumab
-
New Haven, Connecticut
- +3 more
Mar 19, 2021
Malignant Melanoma Trial in New York (Imiquimod, NY-ESO-1 protein)
Completed
- Malignant Melanoma
- Imiquimod
- NY-ESO-1 protein
-
New York, New YorkNYU Cancer Institute
Sep 28, 2020
Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma Trial in United States (Rovalpituzumab tesirine, Dexamethasone)
Terminated
- Malignant Melanoma
- +7 more
- Rovalpituzumab tesirine
- Dexamethasone
-
Gilbert, Arizona
- +29 more
Sep 21, 2020
Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (PF-05082566, rituximab)
Completed
- Lymphoma, Non-Hodgkin
- +6 more
-
Duarte, California
- +41 more
Mar 4, 2020
Malignant Melanoma Trial in Australia, United States (Cobimetinib, vemurafenib)
Completed
- Malignant Melanoma
-
Los Angeles, California
- +9 more
Jul 26, 2019
Malignant Melanoma Trial in Boston, New York (IMC-20D7S (Cohort 1A), IMC-20D7S (Cohort 2A), IMC-20D7S (Cohort 3A))
Completed
- Malignant Melanoma
- IMC-20D7S (Cohort 1A)
- +6 more
-
Boston, Massachusetts
- +1 more
Mar 11, 2019
Malignant Melanoma Trial in New York (ACY-241, nivolumab, ipilimumab)
Completed
- Malignant Melanoma
- ACY-241
- +2 more
-
New York, New YorkNYU Langone Medical Center
Aug 22, 2017
Malignant Melanoma, Colorectal Carcinoma Trial in Australia, United States (PLX4032)
Completed
- Malignant Melanoma
- Colorectal Carcinoma
-
Los Angeles, California
- +6 more
Aug 18, 2017
Malignant Melanoma Trial in Worldwide (Vemurafenib, Dacarbazine)
Completed
- Malignant Melanoma
-
Birmingham, Alabama
- +110 more
Aug 19, 2016
Malignant Melanoma Trial in New York (CP-461)
Terminated
- Malignant Melanoma
-
New York, New YorkColumbia Presbyterian Medical Center
Oct 14, 2011
Melanoma, Metastatic Melanoma, Malignant Melanoma Trial in United States (Allovectin-7®)
Completed
- Melanoma
- +3 more
- Allovectin-7®
-
Tucson, Arizona
- +15 more
Jul 5, 2011